The lopsided tales of a hopeful woman navigating
boobie mountains, genetic jungles,
& the turbulent seas of breast cancer.
Sunday, February 19, 2012
US Patent and Trademark Office
FORCE recently testified to the United States Patent and Trademark Office (USPTO) on the adverse impact that exclusive gene patents has had on hereditary cancer research, interpretation of BRCA testing, and access to care. Learn more here: